Michael Seth Altman Nautilus Biotechnology, Inc. (NAUT) insider trading activity

NAUT Quotes by TradingView

MICHAEL SETH ALTMAN Transaction History

Date Transaction Value Shares Traded Form
Jun 09 2021
SELL
Conversion of derivative security
-
499,000
Jun 09 2021
BUY
Conversion of derivative security
-
4,146,500

Also insider at

ARYD
ARYA Sciences Acquisition Corp IV Financial Services
Chief Financial Officer
LYRA
Lyra Therapeutics, Inc. Healthcare
ARYE
ARYA Sciences Acquisition Corp V Financial Services
Chief Financial Officer
PCSC
Perceptive Capital Solutions Corp
Chief Business Officer
MSA

Michael Seth Altman

Director
New York, NY

Track Institutional and Insider Activities on NAUT

Follow Nautilus Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAUT shares.

Notify only if

Insider Trading

Get notified when an Nautilus Biotechnology, Inc. insider buys or sells NAUT shares.

Notify only if

News

Receive news related to Nautilus Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NAUT